Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-31

Clinical Trial Update: Effect of Neurofast® Supplementation on Anxiety and Cardiovascular Outcomes in the Psycho-Cardio Phenotype Adults [NA]

View source ↗

Summary

Clinical trial update on Neurofast® supplementation addressing anxiety and cardiovascular outcomes in psycho-cardio phenotype adults. The trial has not yet begu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neurofast®

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Anxiety, Cardiovascular Diseases | NA | Status: NOT_YET_RECRUITING